← BACK TO HOMEPAGE ← BACK TO PATREON
ASML // Q2 2026 EARNINGS
THEVALUETRADER RESEARCH
EARNINGS DASHBOARD — JUL 15, 2026
REF: ASML-Q2-2026-EARNINGS

ASML — Q2 2026 Earnings

Sales, margin and net income all clear estimates as AI-driven EUV demand forces a second guidance raise of the year
Headline
Net sales of €9.33B and a 54% margin beat across the board — and full-year guidance jumps to €43–45B as the AI capex cycle keeps accelerating.
TOTAL NET SALES€9.33B — vs €8.80B est.
GROSS MARGIN54.0% — above 51–52% guide
NET INCOME€2.92B — vs €2.62B est. (LSEG)
BASIC EPS€7.59
FY2026 GUIDANCERaised to €43–45B (from €36–40B)
STOCK REACTION+7%+ on the print
φ 01
Beat / Miss Matrix
Cleared the Bar
Beats
  • Net sales €9.33B vs. €8.80B LSEG consensus — a clean top-line beat, +21.3% YoY
  • Gross margin 54.0%, above the company's own 51–52% guided range
  • Net income €2.92B vs. €2.62B expected (LSEG) — an ~11.5% beat
  • New system bookings: 86 new lithography systems shipped in Q2, up from 67 in Q1
  • Q3 2026 guidance of €11.0–12.0B sales sits well above the prior €10.37B consensus
Watch Items
Softer Spots
  • Used lithography systems sold fell to 5 units in Q2, down from 12 in Q1
  • Cash and short-term investments declined to €7.58B from €8.38B in Q1
  • China remains ~20% of total net sales — still a geopolitically exposed revenue base
  • Pre-print, shares had already pulled back 11% in July on AI-capex sustainability and export-control questions ahead of the release
  • Open questions on U.S. BIS/export-compliance posture were not fully addressed on the call, per analyst previews
φ 02
Income Statement Snapshot
NET SALES (Q2 2026 vs Q1 2026)€9.33B vs €8.8B
GROSS MARGIN (Q2 vs Q1)54.0% vs 53.0%
NET INCOME (Q2 vs Q1)€2.92B vs ~€2.8B
INSTALLED BASE MANAGEMENT SALES€2.8B — the key driver of the QoQ sales beat
NEW SYSTEMS SOLD86 units (vs 67 in Q1)
USED SYSTEMS SOLD5 units (vs 12 in Q1)
CASH & ST INVESTMENTS€7.58B (vs €8.38B in Q1)
Q2 SHARE BUYBACKS~€1.1B under 2026–2028 program
INTERIM DIVIDEND€1.88/share — payable Aug 5, 2026

For reference — Q1 2026 (reported April 2026): net sales €8.8B (+13% YoY), gross margin 53.0%, net profit €2.8B (+17%), and a full-year guidance raise to €36–40B from the prior range. Q2's beat and second raise confirm the acceleration first flagged in Q1 has continued rather than plateaued.

φ 03
Business & Technology Detail
EUV & High-NA — The AI Growth Engine
DUV, Metrology & Installed Base
Geographic Mix
φ 04
CEO Commentary
Christophe Fouquet — CEO

"Our customers continue to accelerate their capacity expansion plans, providing ASML with increased visibility into longer-term demand. The end market demand has motivated our customers to increase their CapEx but also accelerate all their plans."

Fouquet also described order intake as "extremely strong" through the first half of 2026, and flagged Intel's move to High-NA EUV production on Panther Lake as "an important milestone" and "proof of the maturity of the tool."

φ 05
Positives & Concerns
Bull Case
Positives
  • A second full-year guidance raise this year — to €43–45B from €36–40B — is direct evidence that AI-driven fab capex is accelerating, not merely holding steady
  • Q3 guidance of €11.0–12.0B sales, with margin guided even higher at 55–57%, sets up for the strongest quarter in company history
  • High-NA EUV's first production use (Intel's Panther Lake) de-risks the platform's next leg of growth and gives ASML a second pricing-power cycle beyond low-NA EUV
  • Memory demand (SK Hynix, Samsung) is now a genuine structural second pillar alongside leading-edge logic, diversifying the AI-capex dependency
  • Continued 30%+ capacity expansion plans for 2027–2028 signal management sees multi-year, not single-quarter, demand visibility
Bear Case
Concerns
  • Shares had already pulled back 11% in the weeks before the print — some of the AI-capex-sustainability skepticism that drove that pullback has not fully cleared
  • China exposure remains sizeable at ~20% of sales; any tightening of U.S. export-control policy (BIS scrutiny referenced in pre-earnings coverage) is a real tail risk for the DUV franchise
  • Cash and short-term investments fell nearly €800M sequentially as buybacks, dividends and capacity investment absorb balance-sheet flexibility
  • Used system sales more than halved QoQ (12 → 5 units) — a smaller data point, but a reminder that not every part of the order book is accelerating uniformly
  • ASML trades at a clear premium (~30x forward earnings) to the broader semi-equipment group (22–25x); that premium requires the guidance raises to keep coming
φ 06
Q3 & Full-Year Guidance
Q3 2026 NET SALES GUIDANCE€11.0B – €12.0B
Q3 2026 GROSS MARGIN GUIDANCE55% – 57%
Q3 R&D / SG&A GUIDANCE~€1.2B R&D / ~€0.4B SG&A
FY2026 NET SALES (NEW)€43B – €45B
FY2026 NET SALES (PRIOR)€36B – €40B
FY2026 GROSS MARGIN GUIDANCE54% – 56%
2027 CAPACITY PLAN (LOW-NA EUV)+30% vs. 2026
2027 CAPACITY PLAN (DUV IMMERSION)+30% vs. 2026
NEXT CAPITAL MARKETS DAYJune 10, 2027
φ 07
Market & Analyst Reaction
φ 08
TVT Verdict — Quick Reference

ASML's position at the top of the semiconductor equipment stack means this print is less a company-specific earnings beat and more a direct readout on the AI infrastructure buildout itself — and the readout was unambiguous. A second full-year guidance raise, margin coming in above the top of its own range, and Intel's confirmed High-NA production use all point the same direction: leading-edge capacity investment is still accelerating, not plateauing, deep into 2026. The China and export-control questions are real and worth tracking, but they sit concentrated in the lower-margin DUV line rather than the EUV franchise that drives the bulk of ASML's economics and its entire monopoly moat. The stock's 11% pre-earnings pullback shows the market had started pricing in an AI-capex-sustainability scare; the 7%+ post-earnings rally shows that scare was, for this quarter at least, not borne out by the numbers. At a premium multiple to peers, ASML's valuation case rests on guidance raises continuing — Q3's €11–12B guide, comfortably above the prior consensus, buys management more room before that thesis is tested again.

Net Sales
€9.33B (+21.3%)
Gross Margin
54.0%
Net Income
€2.92B
FY Guidance
€43–45B (raised)
Stock Reaction
+7%+
Next Earnings
~Mid-Oct 2026
This content is for educational and informational purposes only and reflects TheValueTrader's independent analysis of publicly reported earnings data. It is not financial advice, investment advice, or a recommendation to buy or sell any security. All investing involves risk, and you are responsible for your own decisions. Always do your own research.